Company: LCTX
Filing Date: 2025-06-23
Form Type: 8-K
Source: 0000950170-25-088738
Chunk: 4

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-06-23
Form: 8-K
Item: Item 9.01
Chunk 4
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                  
         99.1      Press release issued on June 23, 2025                                        
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                            Lineage Cell Therapeutics, Inc.          
  Date:      June 23, 2025      By:         /s/ George A. Samuel III                 
                                Name:       George A. Samuel III